How Russia Developed World First Covid-19 Vaccine In Such A Short Span Of Time?

New Delhi: As soon Russian President Vladimir Putin announced world’s first registered vaccine against the novel coronavirus, all the timelines and predictions by the scientists across the world goes wrong. The vaccine, named Sputnik V, was developed by the Gamaleya National Center of Epidemiology and Microbiology, alongside the Russian Direct Investment Fund (RDIF).

Gamaleya Institute has created Sputnik V in much lesser time than what it takes. Speaking on the same, Gamaleya institute Deputy Research Director, Denis Logunov said that it would be wrong to say that they’ve managed to create a vaccine in such a short span of time.

He made the remarks while talking exclusively to the country’s Sputnik News Agency.

“Four decades have passed since adenoviral vector technology was introduced into practice. Over these four decades, a technological platform was created that has been tested on tens of thousands of people, both on the basis of the 5th and the 26th serotype vector. Since 2015, more than 3,000 people have been vaccinated with adenoviral vector-based vaccines developed at the Gamaleya Centre. Therefore, it was not a 5-month effort in any way, but work over several decades”, he asserted.

Meanwhile, Alexander Gintsburg, director of the Gamaleya National Research Center has stated that Russia has planned to produce at least five million doses of the vaccine a month from December through January.